Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macular pigment (MP) refers to the carotenoids lutein, zeaxanthin, and meso-zeaxanthin, which are concentrated in the central retina (macula). These pigments filter blue light and act as antioxidants, protecting photoreceptors from photooxidative damage. Low MP levels are associated with increased risk for age-related macular degeneration (AMD).
Absorption of blue light; Neutralization of reactive oxygen species.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macular Pigment (MP).